These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 32844196

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE.
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F, Rabey JM.
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire.
    Pistacchi M, Gioulis M, Sanson F, Marsala SZ.
    Neurol India; 2017 Dec; 65(6):1271-1279. PubMed ID: 29133700
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.
    N Engl J Med; 2003 Nov 13; 349(20):1925-34. PubMed ID: 14614167
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Long Term Response to Levodopa in Parkinson's Disease.
    Gupta HV, Lyons KE, Wachter N, Pahwa R.
    J Parkinsons Dis; 2019 Nov 13; 9(3):525-529. PubMed ID: 31205007
    [Abstract] [Full Text] [Related]

  • 35. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.
    Schüpbach WM, Chastan N, Welter ML, Houeto JL, Mesnage V, Bonnet AM, Czernecki V, Maltête D, Hartmann A, Mallet L, Pidoux B, Dormont D, Navarro S, Cornu P, Mallet A, Agid Y.
    J Neurol Neurosurg Psychiatry; 2005 Dec 13; 76(12):1640-4. PubMed ID: 16291886
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR.
    Lancet Neurol; 2019 Nov 13; 18(11):998-1008. PubMed ID: 31521532
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the Parkinson's KinetiGraph to off/on levodopa response testing: Single center experience.
    Guan I, Trabilsy M, Barkan S, Malhotra A, Hou Y, Wang F, Hellmers N, Sarva H, Henchcliffe C.
    Clin Neurol Neurosurg; 2021 Oct 13; 209():106890. PubMed ID: 34455169
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Motor complications in Parkinson's disease: ten year follow-up study.
    López IC, Ruiz PJ, Del Pozo SV, Bernardos VS.
    Mov Disord; 2010 Dec 15; 25(16):2735-9. PubMed ID: 20931632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.